Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

Division of Physiological Medicine, St George's Hospital Medical School, London SW17 0RE, UK.
Thorax (Impact Factor: 8.29). 08/1999; 54(7):581-6. DOI: 10.1136/thx.54.7.581
Source: PubMed


Methods of classifying chronic obstructive pulmonary disease (COPD) depend largely upon spirometric measurements but disability is only weakly related to measurements of lung function. With the increased use of pulmonary rehabilitation, a need has been identified for a simple and standardised method of categorising disability in COPD. This study examined the validity of the Medical Research Council (MRC) dyspnoea scale for this purpose.
One hundred patients with COPD were recruited from an outpatient pulmonary rehabilitation programme. Assessments included the MRC dyspnoea scale, spirometric tests, blood gas tensions, a shuttle walking test, and Borg scores for perceived breathlessness before and after exercise. Health status was assessed using the St George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Questionnaire (CRQ). The Nottingham Extended Activities of Daily Living (EADL) score and Hospital Anxiety and Depression (HAD) score were also measured.
Of the patients studied, 32 were classified as having MRC grade 3 dyspnoea, 34 MRC grade 4 dyspnoea, and 34 MRC grade 5 dyspnoea. Patients with MRC grades 1 and 2 dyspnoea were not included in the study. There was a significant association between MRC grade and shuttle distance, SGRQ and CRQ scores, mood state and EADL. Forced expiratory volume in one second (FEV1) was not associated with MRC grade. Multiple logistic regression showed that the determinants of disability appeared to vary with the level of disability. Between MRC grades 3 and 4 the significant covariates were exercise performance, SGRQ and depression score, whilst between grades 4 and 5 exercise performance and age were the major determinants.
The MRC dyspnoea scale is a simple and valid method of categorising patients with COPD in terms of their disability that could be used to complement FEV1 in the classification of COPD severity.

Download full-text


Available from: Janine Bestall, Feb 15, 2014
    • "Description of sensory and affective dimensions of dyspnea will be verified by means of the Multidimensional Dyspnea Profile (MDP) with the last 24 hours as focus period [35, 36]. The mMRC scale [25] and modified Pulmonary Functional Status and Dyspnea Questionnaire [37, 38] will be used to assess impact of dyspnea. For the economic evaluation of morphine SR, participants will complete a prospective costs diary about their health-care use, domestic help and absence of paid or voluntary work. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dyspnea is one of the most reported symptoms of patients with advanced Chronic Obstructive Pulmonary Disease (COPD) and is often undertreated. Morphine has proven to be an effective treatment for dyspnea and is recommended in clinical practice guidelines, but questions concerning benefits and respiratory adverse effects remain. This study primarily evaluates the impact of oral sustained release morphine (morphine SR) on health-related quality of life and respiratory adverse effects in patients with COPD. Secondary objectives include the impact on exercise capacity, the relationship between description and severity of dyspnea and the presence of a clinically relevant response to morphine, and cost-effectiveness.
    No preview · Article · Jan 2016 · Contemporary clinical trials
  • Source
    • "The mMRC does not measure the severity of exertional breathlessness per se, but rather at which activity level dyspnea occurs and the patient's physical limitation.[46] It has high reliability, validity, is useful for characterization and predicting clinical outcomes of patient groups, and is included in the evaluation of COPD severity in the GOLD guidelines.[1,46] However, it has insufficient responsiveness to changes within individuals and is therefore more useful for pure descriptive purposes for detection of changes in clinical trials and practice.[11] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Patient-reported outcomes (PROs), such as symptoms and perceived health status, are essential in chronic obstructive pulmonary disease (COPD) for determining disease severity, impact on daily life, effect of treatment and recovery from exacerbations. This field has evolved rapidly and there are a plethora of instruments assessing different PROs. Here, we aim to provide an understanding of the concept of PROs in COPD. The PROs reflect important aspects of COPD which have a direct impact on daily life. Common symptoms such as dyspnea, cough, phlegm, anxiety, fatigue, and pain and as well as physical function and the risk for and occurrence of acute exacerbations should be assessed both in the clinic and in research. Besides impact on daily life, some of the PROs are related to disease progress and mortality. Construction of composite variables including different disease specific and generic PROs provide a general estimation of health status.
    Full-text · Article · Jan 2016 · Expert Review of Respiratory Medicine
  • Source
    • "Validation Construct validity was assessed using the COSMIN hypothesis testing approach, which refers to the extent to which instrument scores relate to other measures in theoretically consistent ways (Mokkink, Terwee, Knol, et al., 2010; Terwee et al., 2007). To assess construct validity of scores from the Dutch version of the FPI, hypotheses about relationships with the CCQ (van der Molen et al., 2003), the self-administered CRQ-SAS (Williams et al., 2001), and the MRC Dyspnea Scale (Bestall et al., 1999) were formulated. Pearson correlations were estimated . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Performing activities of daily living (ADLs) is an important outcome measure in chronic obstructive pulmonary disease (COPD). The functional performance inventory (FPI) can be used to measure ADL performance in people with COPD. The aims are to report translation of the FPI into the Dutch language and evaluate the validity and reliability of the translated version in a Dutch COPD population. The FPI was translated, after which validation and test-retest reliability studies were conducted. The Consensus-Based Standards for Selection of Health Status Measurement Instruments checklist was used. The Clinical COPD Questionnaire (CCQ), the self-administered Chronic Respiratory Questionnaire-Standardized, and the Medical Research Council Dyspnea Scale were used in the validation study. Test-retest reliability was estimated across 2 weeks in patients with stable COPD. Participants were patients with COPD from the Netherlands who took part in either the validation (n = 90) or reliability study (n = 60). The validity analyses showed that, as hypothesized, the household maintenance and physical exercise subscales of the Dutch version of the FPI had high correlations with the CCQ functional status domain; the total FPI had a correlation of -.44, with CCQ functional status domain. Across the subscales, score reliability estimated with Cronbach's alpha ranged from .55 (Body Care) to .97 (Household Maintenance); total score alpha was .98. Intraclass correlations (ICCs) ranged from .84 (Social Activities) to .97 (Body Care and Household Maintenance); total scale ICC was .98. Recreation and Spiritual Activity subscales varied significantly on retesting at 2 weeks. Scores on the Dutch FPI were reliable and reproducible. Evidence for validity was reasonable, but less strong than that reported in studies from other populations.
    Full-text · Article · Dec 2015 · Nursing research
Show more